<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM ABBOTT
LABORATORIES' 1995 FIRST QUARTER FORM 10-Q AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FORM 10-Q FILING.
</LEGEND>
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLAR
       
                             
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-START>                             JAN-01-1995
<PERIOD-END>                               MAR-31-1995
<EXCHANGE-RATE>                                      1
<CASH>                                         184,210
<SECURITIES>                                    65,842
<RECEIVABLES>                                1,684,892
<ALLOWANCES>                                   135,957
<INVENTORY>                                  1,005,422
<CURRENT-ASSETS>                             3,889,835
<PP&E>                                       7,300,354
<DEPRECIATION>                               3,246,977
<TOTAL-ASSETS>                               8,751,092
<CURRENT-LIABILITIES>                        3,590,608
<BONDS>                                        285,548
<COMMON>                                       524,913
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                   3,605,058
<TOTAL-LIABILITY-AND-EQUITY>                 8,751,092
<SALES>                                      2,524,397
<TOTAL-REVENUES>                             2,524,397
<CGS>                                        1,088,911
<TOTAL-COSTS>                                1,088,911
<OTHER-EXPENSES>                               247,175<F1>
<LOSS-PROVISION>                                25,393
<INTEREST-EXPENSE>                              13,952
<INCOME-PRETAX>                                591,850
<INCOME-TAX>                                   174,596
<INCOME-CONTINUING>                            417,254
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   417,254
<EPS-PRIMARY>                                      .52
<EPS-DILUTED>                                      .52
<FN>
<F1>OTHER EXPENSES CONSIST OF RESEARCH AND DEVELOPMENT EXPENSES
</FN>